BioSapien has a total of 18 patents globally, out of which 6 have been granted. Of these 18 patents, more than 88% patents are active. The United States of America is where BioSapien has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of BioSapien.
BioSapien was founded in 2018. BioSapien is a pre-clinical biotech startup focused on the development of innovative biodegradable implantable solutions that deliver active medicinal components for cancer applications while minimizing systemic side effects. Lung cancer and pancreatic cancer are the two cancers for which this technique is currently being researched.
Do read about some of the most popular patents of BioSapien which have been covered by us in this article and also you can find BioSapien patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over BioSapien patent portfolio.
How many patents does BioSapien have?
BioSapien has a total of 18 patents globally. These patents belong to 2 unique patent families. Out of 18 patents, 16 patents are active.
How Many Patents did BioSapien File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | BioSapien Applications Filed | BioSapien Patents Granted |
| 2023 | – | 2 |
| 2022 | 1 | 2 |
| 2021 | 5 | 2 |
| 2019 | 12 | – |
How many BioSapien patents are Alive/Dead?
Worldwide Patents
How Many Patents did BioSapien File in Different Countries?
Countries in which BioSapien Filed Patents
| Country | Patent |
| United States Of America | 4 |
| Europe | 2 |
| United Kingdom | 2 |
| China | 2 |
| Hong Kong (S.A.R.) | 2 |
| South Africa | 1 |
| Australia | 1 |
| India | 1 |
| Japan | 1 |
Where are Research Centers of BioSapien Patents Located?
The Research Centers of BioSapien Patents is the United States of America.
What Percentage of BioSapien US Patent Applications Were Granted?
BioSapien (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.
Below are the key stats of BioSapien patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for BioSapien?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 3 | 100% |
List of BioSapien patents
| BioSapien Patents | Title |
| US11197945B2 | Biovessels For Use In Tissue Engineering |
| US10926005B2 | Drug-Eluting Surgical Articles With A Plurality Of Geometric Elements |
| US20220233749A1 | Biovessels For Use In Tissue Engineering |
| US20210379251A1 | Drug-Eluting Surgical Articles And Related Methods |
| EP3899995A4 | Drug-Eluting Surgical Articles And Related Methods |
| EP3849467A4 | Biovessels For Use In Tissue Engineering |
| CN113632188B | Drug-Eluting Surgical Articles And Related Methods |
| CN113038908A | Biovessels For Use In Tissue Engineering |
| GB2609310B | Drug-Eluting Surgical Articles And Related Methods |
| GB2598464B | Drug-Eluting Surgical Articles And Related Methods |
| AU2019401451A1 | Drug-Eluting Surgical Articles And Related Methods |
| JP2022500218A | Biological Vessels For Use In Tissue Engineering |
| IN202117032451A | Drug-Eluting Surgical Articles And Related Methods |
| HK40059524A1 | Drug-Eluting Surgical Articles And Related Methods |
| HK40056376A | Biovessels For Use In Tissue Engineering |
| ZA202105114B | Drug-Eluting Surgical Articles And Related Methods |
| WO2020132569A1 | Drug-Eluting Surgical Articles And Related Methods |
| WO2020056248A1 | Biovessels For Use In Tissue Engineering |
What are BioSapien key innovation segments?
What Technologies are Covered by BioSapien?
The chart below distributes patents filed by BioSapien